DaVita (DVA) is an S&P 500 company in Health Care Services. It grades strongest on value and weakest on momentum.
The model's view of DVA· subscribers
Where DVA ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.
Torvanta does not tell individuals what to buy. Its grades for DVA are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.
What is DVA's P/E ratio?
DVA trades at about 14.7 times its last 12 months of GAAP earnings reported to the SEC, and about 13.0 times Torvanta's own estimate of the next 12 months.
When does DVA report earnings next?
Based on its filing history, Torvanta expects DaVita to report around 2026-10-28.
How has DVA performed against the S&P 500?
Over the past year DVA returned +36.3%, against +17.0% for the S&P 500, dividends reinvested.
See the model's view
Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.
Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.